2024 |
MariaDB Plc - Warrants (16/12/2027)
|
Director |
- |
- |
2024 |
MariaDB Plc - Ordinary Shares - Class A
|
Director |
- |
- |
2023 |
MariaDB Plc - Ordinary Shares - Class A
|
Director |
244.6 K |
- |
2023 |
Bellerophon Therapeutics Inc
|
Director |
- |
- |
2022 |
Bellerophon Therapeutics Inc
|
Director |
74.9 K |
-21.2 % |
2022 |
MariaDB Plc - Ordinary Shares - Class A
|
Director |
- |
- |
2022 |
MariaDB Plc - Warrants (16/12/2027)
|
Director |
- |
- |
2021 |
Bellerophon Therapeutics Inc
|
Independent Director |
95.0 K |
-2.4 % |
2021 |
MariaDB Plc - Ordinary Shares - Class A
|
Director |
- |
- |
2021 |
Ekso Bionics Holdings Inc
|
Independent Director |
- |
- |
2020 |
Ekso Bionics Holdings Inc
|
Independent Director |
125.0 K |
66.5 % |
2020 |
Bellerophon Therapeutics Inc
|
Independent Director |
97.4 K |
72.9 % |
2019 |
Ekso Bionics Holdings Inc
|
Independent Director |
75.1 K |
-69.3 % |
2019 |
Bellerophon Therapeutics Inc
|
Independent Director |
56.3 K |
-43.7 % |
2019 |
TRACON Pharmaceuticals Inc
|
- |
17.5 K |
- |
2019 |
TRACON Pharmaceuticals Inc
|
Director |
- |
- |
2018 |
Ekso Bionics Holdings Inc
|
Director |
244.7 K |
482.2 % |
2018 |
Bellerophon Therapeutics Inc
|
Independent Director |
100 K |
136.1 % |
2018 |
TRACON Pharmaceuticals Inc
|
Director |
- |
- |
2017 |
Bellerophon Therapeutics Inc
|
Independent Director |
42.4 K |
- |
2017 |
Ekso Bionics Holdings Inc
|
Director |
42.0 K |
- |
2017 |
TRACON Pharmaceuticals Inc
|
Independent Director |
- |
- |